P1.13A.09 RYZ101 (225Ac-DOTATATE) + Carboplatin + Etoposide + Atezolizumab in Somatostatin Receptor Expressing Extensive-Stage Small-Cell Lung Cancer

Autor: Puri, S., Akerley, W., Langdon, R., Mehr, S., Rivera-Rodriguez, N., Berilgen, J., Rineer, J.M., Mulvey, C., Howell, K., Mansfield, A.S., Parent, E., Thakur, M., Mancini, B., Goldman, J., Calais, J., Bushnell, D., Yuan, Y., Li, J., Pascale, N., Gong, L., Ferreira, D., Hao, Z.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S210-S210
Databáze: ScienceDirect